Esperion Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 39.77. In total, the insiders bought 10.51M and sold 314.74K ESPR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
39.77
Buy 10.51M shares
Sell 314.74K shares
62% Buy Activity
Negligible or No Correlation
Buy Signal Medium Confidence
Mar 13, 2026

Analysis Breakdown:

  • Supported by a positive Insider Power Score of 39.77.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Sep 17, 2025
Sell
Common Stock
S-Sale
Koenig Sheldon L.
President And CEO
CEO / President 28 427
Value: $79.3K
Sep 17, 2025
Sell
Common Stock
S-Sale
Looker Benjamin
General Counsel
Officer 6 267
Value: $17.6K
Jul 17, 2025
Sell
Common Stock
S-Sale
Looker Benjamin
General Counsel
Officer 1 304
Value: $1K
Jul 17, 2025
Sell
Common Stock
S-Sale
Halladay Benjamin
Chief Financial Officer
C-Suite Officer 11
Value: $12
Jul 17, 2025
Sell
Common Stock
S-Sale
Halladay Benjamin
Chief Financial Officer
C-Suite Officer 11
Value: $12
Jul 17, 2025
Sell
Common Stock
S-Sale
Looker Benjamin
General Counsel
Officer 1 304
Value: $1K
Jul 01, 2025
Buy
Stock Option (right to buy)
A-Award
Thompson John Craig
Director
Director 40 000
Value: $40.0K
Jul 01, 2025
Buy
Common Stock
J-Other
Thompson John Craig
Director 0
Value: $0
Jul 01, 2025
Buy
Common Stock
J-Other
Thompson John Craig
Director 0
Value: $0
Jul 01, 2025
Buy
Stock Option (right to buy)
A-Award
Thompson John Craig
Director
Director 40 000
Value: $40.0K
Jun 17, 2025
Sell
Common Stock
S-Sale
Looker Benjamin
General Counsel
Officer 6 422
Value: $7K
Jun 17, 2025
Sell
Common Stock
S-Sale
Koenig Sheldon L.
President And CEO
CEO / President 30 474
Value: $33.8K
Jun 17, 2025
Sell
Common Stock
S-Sale
Halladay Benjamin
Chief Financial Officer
C-Suite Officer 7 229
Value: $8K
Jun 17, 2025
Sell
Common Stock
S-Sale
Halladay Benjamin
Chief Financial Officer
C-Suite Officer 7 229
Value: $8K
Jun 17, 2025
Sell
Common Stock
S-Sale
Koenig Sheldon L.
President And CEO
CEO / President 30 474
Value: $33.8K
Jun 17, 2025
Sell
Common Stock
S-Sale
Looker Benjamin
General Counsel
Officer 6 422
Value: $7K
May 29, 2025
Buy
Common Stock
A-Award
Carroll J Martin
Director
Director 33 000
Value: $28.7K
May 29, 2025
Buy
Stock Option (right to buy)
A-Award
Carroll J Martin
Director
Director 44 000
Value: $38.3K
May 29, 2025
Buy
Common Stock
A-Award
Fischer Seth H. Z.
Director
Director 33 000
Value: $28.7K
May 29, 2025
Buy
Stock Option (right to buy)
A-Award
Fischer Seth H. Z.
Director
Director 44 000
Value: $38.3K
May 29, 2025
Buy
Stock Option (right to buy)
A-Award
Hoffman Robert E.
Director
Director 7 040
Value: $6K
May 29, 2025
Buy
Common Stock
A-Award
Hoffman Robert E.
Director
Director 5 280
Value: $5K
May 29, 2025
Buy
Common Stock
A-Award
Rocamboli Stephen
Director
Director 33 000
Value: $28.7K
May 29, 2025
Buy
Stock Option (right to buy)
A-Award
Rocamboli Stephen
Director
Director 44 000
Value: $38.3K
May 29, 2025
Buy
Common Stock
A-Award
Shepard Jay
Director
Director 33 000
Value: $28.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ESPERION THERAPEUTICS
Esperion Therapeutics
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE